-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Opsens Inc. (TSE:OPS) Expected to Post FY2025 Earnings of $0.02 Per Share
Opsens Inc. (TSE:OPS) Expected to Post FY2025 Earnings of $0.02 Per Share
Opsens Inc. (TSE:OPS – Get Rating) – Equities researchers at Raymond James reduced their FY2025 EPS estimates for shares of Opsens in a research report issued on Wednesday, September 7th. Raymond James analyst R. Sarugaser now anticipates that the company will earn $0.02 per share for the year, down from their prior forecast of $0.03. Raymond James currently has a "Buy" rating and a $6.00 target price on the stock. The consensus estimate for Opsens' current full-year earnings is ($0.06) per share.
Get Opsens alerts:Opsens (TSE:OPS – Get Rating) last released its earnings results on Thursday, July 14th. The company reported C($0.03) earnings per share for the quarter, missing analysts' consensus estimates of C($0.02) by C($0.01). The firm had revenue of C$10.08 million for the quarter, compared to analysts' expectations of C$8.65 million.
Opsens Stock Down 1.4 %
Opsens stock opened at C$2.74 on Friday. Opsens has a twelve month low of C$1.55 and a twelve month high of C$3.74. The firm has a 50 day moving average price of C$2.55 and a 200-day moving average price of C$2.19. The company has a market capitalization of C$298.03 million and a P/E ratio of -46.44. The company has a quick ratio of 4.88, a current ratio of 5.87 and a debt-to-equity ratio of 18.46.About Opsens
(Get Rating)
Opsens Inc develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology.
Featured Stories
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
Receive News & Ratings for Opsens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opsens and related companies with MarketBeat.com's FREE daily email newsletter.
Opsens Inc. (TSE:OPS – Get Rating) – Equities researchers at Raymond James reduced their FY2025 EPS estimates for shares of Opsens in a research report issued on Wednesday, September 7th. Raymond James analyst R. Sarugaser now anticipates that the company will earn $0.02 per share for the year, down from their prior forecast of $0.03. Raymond James currently has a "Buy" rating and a $6.00 target price on the stock. The consensus estimate for Opsens' current full-year earnings is ($0.06) per share.
Opsens Inc.(TSE：OPS-GET Rating)-在9月7日星期三发布的一份研究报告中，Raymond James的股票研究人员下调了对Opsens股票的2025财年每股收益预期。Raymond James分析师R.Sarugaser现在预计，该公司今年的每股收益将为0.02美元，低于此前预测的0.03美元。雷蒙德·詹姆斯目前对该股的评级为买入，目标价为6.00美元。对Opsens目前全年收益的普遍估计是每股0.06美元。
Opsens (TSE:OPS – Get Rating) last released its earnings results on Thursday, July 14th. The company reported C($0.03) earnings per share for the quarter, missing analysts' consensus estimates of C($0.02) by C($0.01). The firm had revenue of C$10.08 million for the quarter, compared to analysts' expectations of C$8.65 million.
Opsens(东京证券交易所股票代码：OPS-GET Rating)最近一次发布财报是在7月14日(星期四)。该公司公布本季度每股收益为0.03加元，低于分析师普遍预期的0.02加元(0.01美元)。该公司本季度营收为1,008万加元，高于分析师预期的865万加元。
Opsens Stock Down 1.4 %
Opsens股价下跌1.4%
About Opsens
关于奥普森
(Get Rating)
(获取评级)
Opsens Inc develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology.
Opsens Inc.开发、制造、安装和销售用于介入心脏病学、部分血流储备(FFR)、石油和天然气以及工业应用的光纤传感器。该公司在医疗和工业两个领域开展业务。医疗部门主要专注于生理测量，如冠状动脉狭窄市场的FFR和DPR；并提供一系列微型光学传感器，用于测量其他医疗设备中的集成应用中的压力和温度，并获得其光学传感器技术的许可。
Featured Stories
专题报道
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
- MarketBeat：回顾一周9/5-9/9
- 为网络安全股创纪录的季度做准备
- 汽车市场正在缓慢复苏，这些股票可能表现优异
- DocuSign是否即将发生重大逆转？
- 石油和天然气股票：投资可再生能源的安全途径
Receive News & Ratings for Opsens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opsens and related companies with MarketBeat.com's FREE daily email newsletter.
接受Opsens Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Opsens和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧